A 53-year-old postmenopausal woman with a history of chronic hypertension, well-controlled on a stable antihypertensive regimen (daily telmisartan), presented with left breast cancer, which was a 3 cm mass, with one palpable mobile left axillary lymph node. Fine needle aspiration (FNA) of the breast mass revealed infiltrating ductal carcinoma, which was estrogen receptor (ER) and progesterone receptor (PR) positive and human epidermal growth factor receptor (HER) 2/neu negative. She underwent breast conserving surgery. In the postoperative period, she developed painful redness, warmth and swelling of the left calf, and an ultrasound and color Doppler of the left leg revealed deep venous thrombosis involving the left popliteal vein. She was anticoagulated, initially with dalteparin then switched over to oral warfarin. Her dose of warfarin stabilized at 6 mg daily and the international normalized ratio (INR) was being maintained at 2. She received adjuvant chemotherapy (four cycles of doxorubicin and cyclophosphamide, and 12 weekly doses of paclitaxel) and adjuvant radiotherapy. After the completion of adjuvant chemotherapy and radiotherapy, she was started on oral tamoxifen. She was called back to the outpatient department (OPD) 2 weeks after starting tamoxifen for evaluation of side effects. The day prior to her scheduled OPD visit, she presented to the emergency department with 1 day history of severe headache, confusion, and irrelevant speech. There was no history of fever, no history of seizures, and examination revealed no focal neurologic deficit. Urgent laboratory parameters in the emergency department included:

Hemoglobin (Hb)-10 g/dl

White blood cell (WBC)-5.2 × 10^e12^ /L

Platelet-133 × 10^e9^ /L

Creatinine-0.9 mg/dl

Na-132 mmol/L

K-4.2 mmol/L

Albumin-3.9 g/dl

Aspartate aminotransferase (AST)-44 U/L

Alanine aminotransferase (ALT)-46 U/L

Bilirubin-1.1 mg/dl

Electrocardiogram (ECG) is shown in [Figure 1](#F1){ref-type="fig"}.

![Electrocardiogram of the patient](SAJC-2-278-g001){#F1}

An urgent computed tomography (CT) scan of the brain was obtained, which is shown in [Figure 2](#F2){ref-type="fig"}.

![Computed tomography brain](SAJC-2-278-g002){#F2}

Which of the following therapeutic interventions was performed next?

Intravenous haloperidol.Intravenous antibiotics.Infusion of fresh frozen plasma.Direct current (DC) cardioversion.Intravenous steroids and whole brain radiotherapy.Neurosurgical evaluation for possibility of surgical resection.

Answer
======

This is a patient with left breast infiltrating ductal cancer cT2cN1M0, Stage IIB, ER+PR+her2neu; who had undergone breast conserving surgery, adjuvant chemotherapy, and radiotherapy; and was on adjuvant hormonal therapy with tamoxifen. She had comorbidities of hypertension and deep venous thrombosis, and was on telmisartan and warfarin. She now presented with acute delirium. Since the basic laboratory parameters including serum electrolytes, renal and hepatic function were normal, metabolic encephalopathy was unlikely to be a cause of the acute confusional state. Her WBC count was normal, and there was no history of fever and no meningeal signs on examination to suggest a diagnosis of acute meningitis. Her ECG revealed normal sinus rhythm, with no evidence of arrhythmia; hence, DC cardioversion was not an appropriate choice. Without establishing the etiology of acute delirium, empirically treating the patient's confusion with haloperidol may not have been appropriate. An urgent computed tomography (CT) scan of the brain was performed, which revealed no evidence of brain metastases, hence intravenous steroids, evaluation for whole brain radiotherapy and neurosurgical evaluation were not appropriate choices. The CT brain revealed subarachnoid hemorrhage. After this diagnosis was made, the patient's coagulation parameters were checked, which revealed that the INR was elevated at 8. The patient was continuing on her usual dose of oral warfarin at 5 mg orally daily, and had not taken any extra doses of warfarin. However, she had started tamoxifen 2 weeks ago, which is a cytochrome CYP2C9 inhibitor, and causes metabolism of the Sisomer of warfarin, leading to increased anticoagulation and bleeding. Since this patient developed acute symptomatic intracranial bleed in the form of a subarachnoid hemorrhage, infusion of fresh frozen plasma was given to rapidly reverse the anticoagulation.
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